Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system

BACKGROUND: Recombinant factor VIII (FVIII), used for haemophilia A therapy, is one of the most challenging among the therapeutic proteins produced in heterologous expression systems. Deletion variant of FVIII, in which the entire domain B is replaced by a short linker peptide, was approved for medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlova, Nadezhda A., Kovnir, Sergey V., Gabibov, Alexandre G., Vorobiev, Ivan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366130/
https://www.ncbi.nlm.nih.gov/pubmed/28340620
http://dx.doi.org/10.1186/s12896-017-0353-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366130/
https://www.ncbi.nlm.nih.gov/pubmed/28340620
http://dx.doi.org/10.1186/s12896-017-0353-6

Ejemplares similares